Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer

被引：31

作者：

Donohoe, Claire L. ^{[1
]}

Phillips, Alexander W. ^{[1
]}

机构：

[1] Royal Victoria Infirm, Noorthern Oesophagogastr Canc Unit, Newcastle Upon Tyne, Tyne & Wear, England

来源：

JOURNAL OF THORACIC DISEASE | 2017年 / 9卷 / 03期

关键词：

PHASE-III TRIAL; NEOADJUVANT CHEMORADIOTHERAPY; RESIDUAL DISEASE; THERAPY; SURGERY; CHEMORADIATION;

D O I：

10.21037/jtd.2017.03.39

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：E282 / E284

页数：3

共 18 条

[1]

[Anonymous], 2017, AJCC CANC STAGING MA

[2] Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort [J].

Cheedella, N. K. S. ;

Suzuki, A. ;

Xiao, L. ;

Hofstetter, W. L. ;

Maru, D. M. ;

Taketa, T. ;

Sudo, K. ;

Blum, M. A. ;

Lin, S. H. ;

Welch, J. ;

Lee, J. H. ;

Bhutani, M. S. ;

Rice, D. C. ;

Vaporciyan, A. A. ;

Swisher, S. G. ;

Ajani, J. A. .

ANNALS OF ONCOLOGY, 2013, 24 (05) :1262-1266

[3] Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database [J].

Crabtree, Traves D. ;

Kosinski, Andrzej S. ;

Puri, Varun ;

Burfeind, William ;

Bharat, Ankit ;

Patterson, Alexander ;

Hofstetter, Wayne ;

Meyers, Bryan F. .

ANNALS OF THORACIC SURGERY, 2013, 96 (02) :382-390

[4] Can CT-PET and Endoscopic Assessment Post-Neoadjuvant Chemoradiotherapy Predict Residual Disease in Esophageal Cancer? [J].

Heneghan, Helen M. ;

Donohoe, Claire ;

Elliot, Jessie ;

Ahmed, Zuhair ;

Malik, Vinod ;

Ravi, Narayamasamy ;

Reynolds, John V. .

ANNALS OF SURGERY, 2016, 264 (05) :831-838

[5] A novel approach to cancer staging: application to esophageal cancer [J].

Ishwaran, Hemant ;

Blackstone, Eugene H. ;

Apperson-Hansen, Carolyn ;

Rice, Thomas W. .

BIOSTATISTICS, 2009, 10 (04) :603-620

[6] The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence [J].

Lagarde, S. M. ;

Phillips, A. W. ;

Navidi, M. ;

Disep, B. ;

Immanuel, A. ;

Griffin, S. M. .

BRITISH JOURNAL OF CANCER, 2015, 113 (10) :1427-1433

[7] The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent [J].

Mariette, Christophe ;

Piessen, Guillaume ;

Briez, Nicolas ;

Triboulet, Jean Pierre .

ANNALS OF SURGERY, 2008, 247 (02) :365-371

[8] Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 [J].

Mariette, Christophe ;

Dahan, Laetitia ;

Mornex, Francoise ;

Maillard, Emilie ;

Thomas, Pascal-Alexandre ;

Meunier, Bernard ;

Boige, Valerie ;

Pezet, Denis ;

Robb, William B. ;

Le Brun-Ly, Valerie ;

Bosset, Jean-Francois ;

Mabrut, Jean-Yves ;

Triboulet, Jean-Pierre ;

Bedenne, Laurent ;

Seitz, Jean-Francois .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) :2416-U201

[9]

Markar SR, 2016, ANN ONCOL

[10] Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol [J].

Noordman, Bo Jan ;

Shapiro, Joel ;

Spaander, Manon C. W. ;

Krishnadath, Kausilia K. ;

van Laarhoven, Hanneke W. M. ;

Henegouwen, Mark I. van Berge ;

Nieuwenhuijzen, Grard A. P. ;

van Hillegersberg, Richard ;

Sosef, Meindert N. ;

Steyerberg, Ewout W. ;

Wijnhoven, Bas P. L. ;

van Lanschot, J. Jan B. .

JMIR RESEARCH PROTOCOLS, 2015, 4 (02)

← 1 2 →